Nutrigenetics, nutrigenomics, and selenium

Frontiers in Genetics

Volumn 2, Issue APR, 2011, Pages

  Ferguson, Lynnette R ^a,b,c   Karunasinghe, Nishi ^b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Nutrigenomics New Zealand   (New Zealand)

Author keywords

Nutrigenetics; Nutrigenomics; Selenium; Selenoprotein

Indexed keywords

EID: 84860771765     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2011.00015     Document Type: Review

References (162)

1. Agamy, O., Ben Zeev, B., Lev, D., Marcus, B., Fine, D., Su, D., Narkis, G., Oflr, R., Hoffmann, C, Leshinsky-Silver, E., Flusser, H., Sivan, S., Soil, D., Lerman-Sagie, T., and Birk, O. S. (2010). Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy. Am. J. Hum. Genet. 87, 538-544.
2. Allmang, C, Wurth, L., and Krol, A. (2009). The selenium to selenopro-tein pathway in eukaryotes: more molecular partners than anticipated. Biochim. Biophys. Acta 1790, 1415-1423.
3. Amar, S., Ovadia, O., Maier, W., Ebstein, R., Belmaker, R. H., Mishmar, D., and Agam, G. (2010). Copy number variation of the SELENBP1 gene in schizophrenia. Behav. Brain Funct. 6,40.
4. Arbogast, S., and Ferreiro, A. (2009). Selenoproteins and protection against oxidative stress: seleno-protein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Antioxid. Redox Signal. 12, 893-904.
5. Arner, E. S. (2010). Selenoproteins - what unique properties can arise with selenocysteine in place of cysteine? Exp. Cell Res. 316, 1296-1303.
6. Ashrafl, M. R., Shabanian, R., Abbaskhanian, A., Nasirian, A., Ghofrani, M., Mohammadi, M., Zamani, G. R., Kayhanidoost, Z., Ebrahimi, S., and Pourpak, Z. (2007a). Selenium and intractable epilepsy: is there any correlation? Pediatr. Neurol. 36,25-29.
7. Ashrafl, M. R., Shams, S., Nouri, M., Mohseni, M., Shabanian, R., Yekaninejad, M. S., Chegini, N., Khodadad, A., and Safaralizadeh, R. (2007b). A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis. Epilepsia 48, 1750-1755.
8. Baliga, M. S., Wang, H., Zhuo, P., Schwartz, J. L., and Diamond, A. M. (2007). Selenium and GPx-1 over-expression protect mammalian cells against UV-induced DNA damage. Biol. Trace Elem. Res. 115,227-242.
9. Bartel, J., Bartz, T., Wolf, C, Charkiewicz, E., Kuhbacher, M., Pohl, T., and Kyriakopoulos, A. (2007). Activity of the glutathione peroxidase-2. Differences in the selenium-dependent expression between colon and small intestine. Cancer Genomics Proteomics 4, 369-372.
10. Bartel, J., Charkiewicz, E., Bartz, T., Bartel, J., Schmidt, D., Grbavac, I., and Kyriakopoulos, A. (2010). Metallo-proteome of the prostate: carcinoma cell line DU-145 in comparison to healthy rat tissue. Cancer Genomics Proteomics 7,81-86.
11. Berjanskii, M., Tang, P., Liang, J., Cruz, J. A., Zhou, J., Zhou, Y., Bassett, E., Macdonell, C, Lu, P., Lin, G., and Wishart, D. S. (2009). GeNMR: a web server for rapid NMR-based protein structure determination. Nucleic Acids Res. 37, W670-W677.
12. Bermano, G., Pagmantidis, V., Holloway, N., Kadri, S., Mowat, N. A. G., Shiel, R. S., Arthur, J. R., Mathers, J. C, Daly, A. K., Broom, J., and Hesketh, J. E. (2007). Evidence that a polymorphism within the 3;UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr. 2, 225-232.
13. Bleys, J., Navas-Acien, A., Stranges, S., Menke, A., Miller, E. R. Ill, and Gual-lar, E. (2008). Serum selenium and serum lipids in US adults. Am. J. Clin.Nutr. 88,416-423.
14. Carlson, B. A., Yoo, M.-H., Sano, Y, Sen-gupta, A., Kim, I. Y, Irons, R., Glady-shev, V. N., Hatfield, D. L, and Park, I. M. (2009). Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression. BMC Immunol. 10, 57. doi: 10.1186/1471-2172-10-57
15. Castellano, S., Gladyshev, V. N., Guigo, R., and Berry, M. I. (2008). Selen-oDB 1.0: a database of selenoprotein genes, proteins and SECIS elements. Nucleic Acids Res. 36, D332-D338.
16. Chen, Y.-C, Sosnoski, D. M., Gandhi, U. H., Novinger, L. I., Prabhu, K. S., and Mastro, A. M. (2009). Selenium modifies the osteoblast inflammatory stress response to bone metasta-tic breast cancer. Carcinogenesis 30, 1941-1948.
17. Chiang, E. C., Shen, S., Kengeri, S. S., Xu, H., Combs, G. E, Morris, J. S., Bost-wick, D. G., and Waters, D. J. (2009). Denning the optimal selenium dose for prostate cancer risk reduction: insights from the u-shaped relationship between selenium status, dna damage, and apoptosis. Dose Response 8,285-300.
18. Chun, J. Y., Hu, Y., Pinder, E., Wu, J., Li, E, and Gao, A. C. (2007). Selenium inhibition of survivin expression by preventing Spl binding to its promoter. Mol Cancer Ther. 6, 2572-2580.
19. Clark, L. C, Combs, G. F. Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Kron-grad, A., Lesher, J. L. Jr., Park, H. K., Sanders, B. B. Jr., Smith, C. L., and Taylor, J. R. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963. [Erratum appears in JAMA 1997 May 21;277, 1520].
20. Clark, L. C, Dalkin, B., Krongrad, A., Combs, G. F. Jr., Turnbull, B. W., Slate, E. H., Witherington, R., Her-long, J. H., Janosko, E., Carpenter, D., Borosso, C, Falk, S., and Rounder, J. (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol 81,730-734.
21. Clark, L. C, Hixson, L. J., Combs, G. F. Jr., Reid, M. E., Turnbull, B. W., and Sampliner, R. E. (1993). Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Bio-markers Prev. 2,41-46.
22. Clark, L. C, and Jacobs, E. T. (1998). Environmental selenium and cancer: risk or protection? Cancer Epidemiol Biomarkers Prev. 7, 847-848; discussion 851-842.
23. Combs, G. F. Jr., Clark, L. C, and Turn-bull, B. W. (1997). Reduction of cancer mortality and incidence by selenium supplementation. Med. Klin. 92(Suppl. 3), 42-45.
24. Cook, E. D., Moody-Thomas, S., Anderson, K. B., Campbell, R., Hamilton, S. J., Harrington, J. M., Lippman, S. M., Minasian, L. M., Paskett, E. D., Craine, S., Arnold, K. B., and Probst-field, J. L. (2005). Minority recruitment to the selenium and vitamin E cancer prevention yrial (SELECT). Clin. Trials 2, 436-442.
25. Cooper, M. L., Adami, H.-O., Gron-berg, H., Wiklund, E, Green, F. R., and Rayman, M. P. (2008). Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dis-mutase determines prostate cancer risk. Cancer Res. 68, 10171-10177.
26. Curran, J. E., Jowett, J. B. M., Elliot, K. S., Gao, Y, Glaschenko, K., Wang, J., Azim, D. M. A., Cai, G., Mahaney, M. C, Comuzzie, A. G., Dyer, T. D., Walder, K. R., Zimmet, P., Maccluer, W., Collier, G. R., Kissebah, A. H., andBlangero, J. (2005). Geneticvari-ation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234-1241.
27. Daniel, H., Drevon, C. A., Klein, U. I., Kleemann, R., and Van Ommen, B. (2008). The challenges for molecular nutrition research 3: comparative nutrigenomics research as a basis for entering the systems level. Genes Nutr.3, 101-106.
28. Darlow, B. A., Inder, T. E., Sluis, K. B., Nuthall, G., Mogridge, N., and Win-terbourn, C. C. (1995). Selenium status of New Zealand infants fed either a selenium supplemented or a standard formula. J. Paediatr. Child Health 31, 339-344.
29. Davis, C. D., and Milner, J. A. (2006). "Incorporating 'omics' approaches to elucidate the role of selenium and selenoproteins in cancer prevention," in Selenium It's Molecular Biology and Role in Human Health, 2nd Edn, eds D. L. Hatfield, M. J. Berry, and V. N. Gladyshev (New York: Springer), 367-378.
30. De Jong, N., Gibson, R. S., Thomson, C. D., Ferguson, E. L., Mckenzie, J. E., Green, T. J., and Horwath, C. C. (2001). Selenium and zinc status are suboptimal in a sample of older New Zealand women in a community-based study. J. Nutr. 131,2677-2684.
31. Dolamore, B. A., Brown, J., Darlow, B. A., George, P. M., Sluis, K. B., and Winterbourn, C. C. (1992). Selenium status of Christchurch infants and the effect of diet. N. Z. Med. J. 105,139-142.
32. Duffield, A. J., Thomson, C. D., Hill, K. E., and Williams, S. (1999). An estimation of selenium requirements for New Zealanders. Am. J. Clin. Nutr. 70, 896-903.
33. Duffield-Lillico, A. J., Dalkin, B. L., Reid, M. E., Turnbull, B. W, Slate, E. H., Jacobs, E. T., Marshall, J. R., Clark, L. C, and Nutritional Prevention of Cancer Study Group. (2003a). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 91, 608-612.
34. Duffield-Lillico, A. J., Slate, E. H., Reid, M. E., Turnbull, B. W, Wilkins, P. A., Combs, G. F. Jr., Park, H. K., Gross, E. G., Graham, G. F., Strat-ton, M. S., Marshall, J. R., Clark, L. C, and Nutritional Prevention of Cancer Study Group. (2003b). Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J. Natl. Cancerlnst. 95, 1477-1481.
35. Duffield-Lillico, A. J., Reid, M. E., Turn-bull, B. W., Combs, G. F. Jr., Slate, E. H., Fischbach, L. A., Marshall, J. R., and Clark, L. C. (2002). Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: asummaryreport of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 11,630-639.
36. Dunn, B. K., Ryan, A., and Ford, L. G. (2009). Selenium and vitamin E cancer prevention trial: a nutrient approach to prostate cancer prevention. Recent Results Cancer Res. 181, 183-193.
37. Duntas, L. H. (2010). Selenium and the thyroid: a close-knit connection. J. Clin. Endocrinol. Metab. 95, 5180-5188.
38. Erickson, K. L., Medina, E. A., and Hub-bard, N. E. (2000). Micronutrients and innate immunity. J. Infect. Dis. 182(Suppl. l), S5-S10.
39. Erickson, R. P. (2010). Somatic gene mutation and human disease other than cancer: an update. Mutat. Res. 705, 96-106.
40. Fairweather-Tait, S. J., Collings, R., and Hurst, R. (2010). Selenium bioavailability: current knowledge and future research requirements. Am. J. Clin. Nutr. 91, 1484S-1491S. [Erratum appears in Am. J. Clin. Nutr. 2010 Oct;92,1002].
41. Fan, T. W M., Higashi, R. M., and Lane, A. N. (2006). Integrating metabolomics and transcrip-tomics for probing SE anticancer mechanisms. Drug Metab. Rev. 38, 707-732.
42. Ferguson, L. R. (2009). Epige-netic variation and customising nutritional intervention. Curr. Pharmacogenomics Person Med. 7, 115-124.
43. Ferguson, L. R., Philpott, M., and Karunasinghe, N. (2006). Oxidative DNA damage and repair: significance and biomarkers. J. Nutr. 136, 2687S-2689S.
44. Flohe, L. (2007). Selenium in mammalian spermiogenesis. Biol. Chem. 388, 987-995.
45. Flohe, L. (2010). Changing paradigms in thiology from antioxidant defense toward redox regulation. Meth. Enzymol. 473, 1-39.
46. Forsythe, I. J.,and Wishart, D. S. (2009). Exploring human metabolites using the human metabolome database. Curr. Protoc. Bioinformatics 14, Unit 14.18.
47. Franke, A., McGovern, D. P., Barrett, J. C, Wang, K., Radford-Smith, G. L, Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., Anderson, C. A., Bis, J. C, Bumpstead, S., Elling-haus, D., Festen, E. M., Georges, M., Green, T., Haritunians, T., Jostins, L., Latiano, A., Mathew, C. G., Montgomery, G. W, Prescott, N. J., Ray-chaudhuri, S., Rotter, J. I., Schumm, P., Sharma, Y, Simms, L. A., Taylor, K. D., Whiteman, D., Wijmenga, C, Baldassano, R. N., Barclay, M., Bayless, T. M., Brand, S., Biining, C, Cohen, A., Colombel, J. F., Cot-tone, M., Stronati, L., Denson, T., De Vos, M., D'Inca, R., Dubinsky, M., Edwards, C, Florin, T., Franchi-mont, D., Gearry, R., Glas, J., Van Gossum, A., Guthery, S. L., Halfvar-son, J., Verspaget, H. W., Hugot, J. P., Karban, A., Laukens, D., Lawrance, I., Lemann, M., Levine, A., Libioulle, C, Louis, E., Mowat, C, Newman, W, Panes, J., Phillips, A., Proctor, D. D., Regueiro, M., Russell, R., Rutgeerts, P., Sanderson, J., Sans, M., Seibold, E, Steinhart, A. H., Stokkers, P. C, Torkvist, L, Kullak-Ublick, G., Wilson, D., Walters, T., Targan, S. R., Brant, S. R., Rioux, J. D., D'Amato, M., Weersma, R. K., Kugathasan, S., Griffiths, A. M., Mansfield, J. C, Vermeire, S., Duerr, R. H., Silver-berg, M. S., Satsangi, J., Schreiber, S., Cho, J. H., Annese, V, Hakonar-son, H., Daly, M. J., and Parkes, M. (2010). Genome-wide meta-analysis increases to 71 the num ber of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125.
48. Gao, S., Jin, Y., Hall, K. S., Liang, C, Unverzagt, F. W, Ma, E, Cheng, Y, Shen, J., Cao, J., Matesan, J., Li, P., Bian, J., Hendrie, H. C, and Murrell, J. R. (2009). Selenium level is associated with apoE epsilon4 in rural elderly Chinese. Public Health Nutr. 12,2371-2376.
49. Georgieff, M. K. (2007). Nutrition and the developing brain: nutrient priorities and measurement. Am. J. Clin. Nutr. 85, 614S-620S
50. Gladyshev, V N., Kryukov, G. V, Fomenko, D. E., and Hatfield, D. L. (2004). Identification of trace element-containing proteins in genomic databases. Annu. Rev. Nutr. 24, 579-596.
51. Gore, E, Fawell, J., and Bartram, J. (2010). Too much or too little? A review of the conundrum of selenium. J. Water Health 8, 405-416.
52. Guijian, L., Liugen, Z., Duzgoren-Aydin, N. S., Lianfen, G., Junhua, L., and Zicheng, P. (2007). Health effects of arsenic, fluorine, and selenium from indoor burning of Chinese coal. Rev. Environ. Contam. Toxicol. 189,89-106.
53. Hawkes, W. C, and Alkan, Z. (2010). Regulation of redox signaling by selenoproteins. Biol. Trace Elem. Res. 134,235-251.
54. Hesketh, J. (2008). Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu. Rev. Nutr. 28,157-177.
55. Hesketh, J., Wybranska, I., Dommels, Y., King, M., Elliott, R., Pico, C, and Keijer, J. (2006). Nutrient-gene interactions in benefit-risk analysis. Br.J. Nutr. 95,1232-1236.
56. Hesketh, J. E., and Villette, S. (2002). Intracellular trafficking of micronu-trients: from gene regulation to nutrient requirements. Proc. Nutr. Soc. 61,405-414.
57. Higuchi, A., Takahashi, K., Hirashima, M., Kawakita, T., and Tsubota, K. (2010). Selenoprotein P controls oxidative stress in cornea. PLoS ONE 5, e9911. doi: 10.1371/jour-nal.pone.0009911
58. Hoeflich, J., Hollenbach, B., Behrends, T., Hoeg, A., Stosnach, H., and Schomburg, L. (2010). The choice of biomarkers determines the selenium status in young German vegans and vegetarians. Br. J. Nutr. 104, 1601-1604.
59. Hon, K.-L. E., Wang, S. S., Hung, E. C. W., Lam, H. S., Lui, H. H. K., Chow, C.-M., Ching, G. K. W., Fok, T.-E, Ng, P.-C, and Leung, T.-E (2010). Serum levels of heavy metals in childhood eczema and skin diseases: friends or foes. Pediatr. Allergy Immunol. 21,831-836.
60. Hoque, A., Albanes, D., Lippman, S. M., Spitz, M. R., Taylor, P. R., Klein, E. A., Thompson, I. M., Goodman, P., Stanford, J. L., Crowley, J. J., Coltman, C. A., and Santella, R. M. (2001). Molecular epidemiologic studies within the selenium and vitamin E cancer prevention trial (SELECT). Cancer Causes Control 12, 627-633.
61. Hu, Y. J., Korotkov, K. V., Mehta, R., Hatfield, D. L, Rotimi, C. N., Luke, A., Prewitt, T. E., Cooper, R. S., Stock, W., Vokes, E. E., Dolan, M. E., Gladyshev, V. N., and Diamond, A. M. (2001). Distribution and functional consequences of nucleotide polymorphisms in the 3;-untranslated region of the human Sepl5 gene. Cancer Res. 61, 2307-2310.
62. Johnson, A. D. (2009). Single-nucleotide polymorphism bioinfor-matics: a comprehensive review of resources. Circ. Cardiovasc. Genet. 2, 530-536.
63. Johnson, C. C, Fordyce, E M., and Ray-man, M. P. (2010). Symposium on "geographical and geological influences on nutrition": factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc. Nutr. Soc. 69,119-132.
64. Joost, H.-G., Gibney, M. J., Cashman, K. D., Gorman, U., Hesketh, J. E., Mueller, M., Van Ommen, B., Williams, C. M., and Mathers, J. C. (2007). Personalised nutrition: status and perspectives. Br. J. Nutr. 98, 26-31.
65. Kant, A. K., and Graubard, B. I. (2007). Ethnicity is an independent correlate of biomarkers of micronutrient intake and status in American adults. J.Nutr. 137,2456-2463.
66. Kaput, J. (2008). Nutrigenomics research for personalized nutrition and medicine. Curr. Opin. Biotechnol. 19, 110-120.
67. Karunasinghe, N., Ryan, J., Tuckey, J., Masters, J., Jamieson, M., Clarke, L. C, Marshall, J. R., and Ferguson, L. R. (2004). DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol. Biomarkers Prev. 13, 391-397.
68. Kibriya, M. G., Jasmine, E, Argos, M., Verret, W J., Rakibuz-Zaman, M., Ahmed, A., Parvez, F., and Ahsan, H. (2007). Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol. Lett. 169, 162-176.
69. Kipp, A., Banning, A., Van Schothorst, E. M., Meplan, C, Schomburg, L., Evelo, C, Coort, S., Gaj, S., Keijer, J., Hesketh, J., and Brigelius-Flohe, R. (2009). Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Mol. Nutr. Food Res. 53, 1561-1572.
70. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R., and Coltman, C. (2001). SELECT: the next prostate cancer prevention trial. Selenum and vitamin E cancer prevention trial. J. Urol. 166, 1311-1315.
71. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R., and Coltman, C. (2003). SELECT: the selenium and vitamin E cancer prevention trial. Urol. Oncol. 21,59-65.
72. Kohonen-Corish, M. R. J., Al-Aama, J. Y., Auerbach, A. D., Axton, M., Barash, C. I., Bernstein, I., Beroud, C, Burn, J., Cunningham, F., Cutting, G. R., Den Dunnen, J. T., Green-blatt, M. S., Kaput, J., Katz, M., Lindblom, A., Macrae, F., Maglott, D., Moslein, G., Povey, S., Rame-sar, R., Richards, S., Seminara, D., Sobrido, M.-J., Tavtigian, S., Taylor, G., Vihinen, M., Winship, I., Cot ton, R. G. H., and Human Variome Project Meeting. (2010). How to catch all those mutations - the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010. Hum. Mutat. 31,1374-1381.
73. Korotkov, K. V, Kumaraswamy, E., Zhou, Y, Hatfield, D. L, and Gladyshev, V N. (2001). Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glu-cosyltransferase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 276, 15330-15336.
74. Kumaraswamy, E., Korotkov, K. V, Diamond, A. M., Gladyshev, V N., and Hatfield, D. L. (2002). Genetic and functional analysis of mammalian Sep 15 selenoprotein. Meth. Enzymol 347, 187-197.
75. Labunsky, V. M., Gladyshev, V N., and Hatfield, D. L. (2006). "The 15-kDa selenoprotein (Sepl5): functional analysis and role in cancer," in Selenium It's Molecular Biology and Role in Human Health, 2nd Edn, eds D. L. Hatfield, M. J. Berry, and V N. Gladyshev (New York: Springer), 141-148.
76. Labunskyy, V M., Hatfield, D. L., and Gladyshev, V N. (2007). The Sepl5 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. IUBMB Life 59,1-5.
77. Labunskyy, V M., Yoo, M.-H., Hatfield, D. L., and Gladyshev, V N. (2009). Sepl5, a thioredoxin-like selenoprotein, is involved in the unfolded protein response and differentially regulated by adaptive and acute ER stresses. Biochemistry 48, 8458-8465.
78. Lee, C, and Scherer, S. W (2010). The clinical context of copy number variation in the human genome. Expert Rev. Mol. Med. 12, e8.
79. Lei, X. G., Cheng, W.-H., and McclungJ. P. (2007). Metabolic regulation and function of glutathione peroxidase-1. Annu. Rev. Nutr. 27, 41-61.
80. Lescure, A., Rederstorff, M., Krol, A., Guicheney, P., and Allamand, V (2009). Selenoprotein function and muscle disease. Biochim. Biophys. Acta 1790, 1569-1574.
81. Levander, O. A. (1991). Scientific rationale for the 1989 recommended dietary allowance for selenium. J. Am. Diet. Assoc. 91, 1572-1576.
82. Li, H., Kantoff, P. W., Giovannucci, E., Leitzmann, M. E, Gaziano, J. M., Stampfer, M. J., and Ma, J. (2005). Manganese superoxide dis-mutase polymorphism, prediagnos-tic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res. 65, 2498-2504.
83. Lietz, G., and Hesketh, J. (2009). A network approach to micronutrient genetics: interactions with lipid metabolism. Curr. Opin. Lipidol. 20, 112-120.
84. Lin, H.-M., Barnett, M. P., Roy, N. C, Joyce, N. I., Zhu, S., Armstrong, K., Helsby, N. A., Ferguson, L. R., and Rowan, D. D. (2010). Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. J. Proteome Res. 9, 1965-1975.
85. Lippman, S. M., Goodman, P. J., Klein, E. A., Parnes, H. L., Thompson, I. M. Jr., Kristal, A. R., Santella, R. M., Probstfield, J. L., Moinpour, C. M., Albanes, D., Taylor, P. R., Minasian, L. M., Hoque, A., Thomas, S. M., Crowley, J. J., Gaziano, J. M., Stan ford, J. L, Cook, E. D., Fleshner, N. E., Lieber, M. M., Walther, P. J., Khuri, F. R., Karp, D. D., Schwartz, G. G., Ford, L. G., and Coltman, C. A., Jr. (2005). Designing the selenium and vitamin E cancer prevention trial (SELECT). J. Nail. Cancer Inst. 97, 94-102.
86. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., Parnes, H. L., Minasian, L. M., Gaziano, J. M., Hartline, J. A., Parsons, J. K., Bearden, J. D. Ill, Crawford, E. D., Goodman, G. E., Claudio, J., Winquist, E., Cook, E. D., Karp, D. D., Walther, P., Lieber, M. M., Kristal, A. R., Darke, A. K., Arnold, K. B., Ganz, P. A., Santella, R. M., Albanes, D., Taylor, P. R., Probstfield, J. L., Jagpal, T. J., Crowley, J. J., Meyskens, F. L. Jr., Baker, L. H., and Coltman, C. A. Jr. (2009). Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 301,39-51.
87. Lobanov, A. V, Hatfield, D. L., and Gladyshev, V N. (2009). Eukary-otic selenoproteins and selenopro-teomes. Biochim. Biophys. Acta 1790, 1424-1428.
88. Logan, J. W. (1988). Selenium and the north south gradient in cot death. NZ.MedJ. 101,832.
89. Logan, J. W. (1991). Food for New Zealanders: high iodine, low selenium status. N Z. Med. J. 104, 432.
90. Madeja, Z., Sroka, J., Nystrom, C, Bjorkhem-Bergman, L., Nordman, T., Damdimopoulos, A., Nalvarte, I., Eriksson, L. C, Spyrou, G., Olsson, J. M., and Bjornstedt, M. (2005). The role of thioredoxin reductase activity in selenium-induced cytotoxicity. Biochem. Pharmacol. 69,1765-1772.
91. Maggini, S., Wintergerst, E. S., Bev-eridge, S., and Homig, D. H. (2007). Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br. J. Nutr. 98(Suppl. 1), S29-S35.
92. Mahn, A. V., Munoz, M. C, and Zamorano, M. J. (2009). Discovery of biomarkers that reflect the intake of sodium selenate by nutritional proteomics. J. Chromatogr. Sci. 47, 840-843.
93. Mathers, J. C, and Hesketh, J. E. (2007). The biological revolution: understanding the impact of SNPs on diet-cancer interrelationships. J. Nutr. 137, 253S-258S.
94. Meplan, C. (2011). Trace elements and ageing, a genomic perspective using selenium as an example. J. Trace Elem. Med. Biol 25(Suppl. 1), S11-S16.
95. Meplan, C, Crosley, L. K., Nicol, E, Beckett, G. J., Howie, A. E, Hill, K. E., Horgan, G., Mathers, J. C, Arthur, J. R., and Hesketh, J. E. (2007). Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J. 21,3063-3074.
96. Meplan, C, Crosley, L. K., Nicol, E, Horgan, G. W., Mathers, J. C, Arthur, J. R., and Hesketh, J. E. (2008). Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glu-tathione peroxidase 4 gene: interaction with sex. Am. J. Clin. Nutr. 87, 1019-1027.
97. Meplan, C, Hughes, D. J., Pardini, B., Naccarati, A., Soucek, P., Vod-ickova, L., Hlavata, I., Vrana, D., Vodicka, P., and Hesketh, J. E. (2010). Genetic variants in selenoprotein genes increase risk of col-orectal cancer. Carcinogenesis 31, 1074-1079.
98. Meplan, C, Nicol, E, Burtle, B. T., Crosley, L. K., Arthur, J. R., Mathers, J. C, and Hesketh, J. E. (2009). Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid. Redox Signal. 11, 2631-2640.
99. Mithen, R. (2007). Effect of genotype on micronutrient absorption and metabolism: a review of iron, copper, iodine and selenium, and folates. Int.. Vitam. Nutr. Res. 77, 205-216.
100. Mueller, A. S., Mueller, K., Wolf, N. M., and Pallauf, J. (2009). Selenium and diabetes: an enigma? Free Radic. Res. 43, 1029-1059.
101. Navarro-Alarcon, M., and Cabrera-Vique, C. (2008). Selenium in food and the human body: a review. Sci. Total Environ. 400,115-141.
102. Nelson, M. A., Porterfield, B. W., Jacobs, E. T., and Clark, L. C. (1999). Selenium and prostate cancer prevention. Semin. Urol Oncol. 17, 91-96.
103. Nordman, T., Xia, L., Bjorkhem-Bergman, L., Damdimopoulos, A., Nalvarte, I., Arner, E. S. J., Spyrou, G., Eriksson, L. C, Bjornstedt, M., and Olsson, J. M. (2003). Regeneration of the antioxidant ubiquinol by lipoamide dehydrogenase, thioredoxin reductase and glutathione reductase. Biofactors 18,45-50.
104. Novoselov, S. V., Kryukov, G. V., Xu, X.-M., Carlson, B. A., Hatfield, D. L, and Gladyshev, V. N. (2007). Selenoprotein H is a nucleolar thioredoxin-like protein with a unique expression pattern. J. Biol. Chem. 282, 11960-11968.
105. Pagmantidis, V., Meplan, C, Van Schothorst, E. M., Keijer, J., and Hesketh, J. E. (2008). Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes. Am. Clin. Nutr. 87,181-189.
106. Papp, L. V., Lu, J., Holmgren, A., and Khanna, K. K. (2007). From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid. Redox Signal. 9, 775-806.
107. Parts, L., Stegle, O., Winn, J., and Durbin, R. (2011). Joint genetic analysis of gene expression data with inferred cellular phenotypes. PLoS Genet. 7, el001276. doi: 10.1371/journal.pgen.l001276
108. Penney, K. L., Schumacher, F. R., Li, H., Kraft, P., Morris, J. S., Kurth, T., Mucci, L. A., Hunter, D. J., Kantoff, P. W., Stampfer, M. J., and Ma, J. (2010). A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev. Res. 3, 604-610.
109. Peters, U., Chatterjee, N., Hayes, R. B., Schoen, R. E., Wang, Y., Chanock, S. J., and Foster, C. B. (2008). Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 17, 1144-1154.
110. Pico, A. R., Kelder, T., Van Iersel, M. P., Hanspers, K., Conklin, B. R., and Evelo, C. (2008). WikiPath-ways: pathway editing for the people. PLoS Biol. 6,el84. doi:10.1371/jour-nal.pbio.0060184
111. Platz, E. A. (2010). Is prostate cancer prevention with selenium all in the genes? Cancer Prev. Res. 3, 576-578.
112. Rayman, M. P. (2008). Food-chain selenium and human health: emphasis on intake. Br.J. Nutr. 100, 254-268.
113. Rayman, M. P. (2009). Selenoproteins and human health: insights from epidemiological data. Biochim. Bio-phys. Acta 1790, 1533-1540.
114. Reid, M. E., Stratton, M. S., Lillico, A. J., Fakih, M., Natarajan, R., Clark, L. C, and Marshall, J. R. (2004). A report of high-dose selenium supplementation: response and toxicities. J. Trace Elem. Med. Biol. 18, 69-74.
115. Robinson, M. E (1989). Selenium in human nutrition in New Zealand. Nutr. Rev. 47, 99-107.
116. Rusyniak, D. E., Arroyo, A., Acciani, J., Froberg, B., Kao, L., and Furbee, B. (2010). Heavy metal poisoning: management of intoxication and antidotes. EXS 100, 365-396.
117. Sakr, Y., Reinhart, K., Bloos, E, Marx, G., Russwurm, S., Bauer, M., and Brunkhorst, F. (2007). Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br. J. Anaesth. 98, 775-784.
118. Sarveswaran, S., Liroff, J., Zhou, Z., Nikitin, A. Y., and Ghosh, J. (2010). Selenite triggers rapid transcrip-tional activation of p53, and p53-mediated apoptosis in prostate cancer cells: implication for the treatment of early-stage prostate cancer. Int. J. Oncol. 36,1419-1428.
119. Savaskan, N. E., Ufer, C, Kuhn, H., and Borchert, A. (2007). Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function. Biol. Chem. 388, 1007-1017.
120. Schoenmakers, E., Agostini, M., Mitchell, C, Schoenmakers, N., Papp, L., Rajanayagam, O., Padidela, R., Ceron-Gutierrez, L., Doffin-ger, R., Prevosto, C, Luan, J. A., Montano, S., Lu, J., Castanet, M., demons, N., Groeneveld, M., Castets, P., Karbaschi, M., Aitken, S., Dixon, A., Williams, J., Campi, I., Blount, M., Burton, H., Muntoni, F., O'donovan, D., Dean, A., Warren, A., Brierley, C, Baguley, D., Guicheney, P., Fitzgerald, R., Coles, A., Gaston, H., Todd, P., Holmgren, A., Khanna, K. K., Cooke, M., Semple, R., Hal-sail, D., Wareham, N., Schwabe, J., Grasso, L., Beck-Peccoz, P., Ogunko, A., Dattani, M., Gurnell, M., and Chatterjee, K. (2010). Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Investig. 120, 4220-4235.
121. Schomburg, L., and Schweizer, U. (2009). Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim. Biophys. Acta 1790, 1453-1462.
122. Schrauzer, G. N. (2009). RE: lessons from the selenium and vitamin E cancer prevention trial (SELECT). Crit. Rev. Biotechnol. 29, 81.
123. Schrauzer, G. N., and Surai, P. E (2009). Selenium in human and animal nutrition: resolved and unresolved issues. A partly historical treatise in commemoration of the fiftieth anniversary of the discovery of the biological essentiality of selenium, dedicated to the memory of Klaus Schwarz (1914-1978) on the occasion of the thirtieth anniversary of his death. Crit. Rev. Biotechnol. 29, 2-9.
124. Shi, X. W, Guo, X., Ren, E L, Li, J., and Wu, X. M. (2010). The effect of short tandem repeat loci and low selenium levels on endemic osteoarthritis in China. J. Bone joint Surg Am. 92, 72-80.
125. Steinbrecher, A., Meplan, C, Hesketh, J., Schomburg, L., Endermann, T., Jansen, E., Akesson, B., Rohrmann, S., and Linseisen, J. (2010). Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol. Biomarkers Prev. 19,2958-2968.
126. Steinbrenner, H., and Sies, H. (2009). Protection against reactive oxygen species by selenoproteins. Biochim. Biophys. Acta 1790, 1478-1485.
127. Sutherland, A., Kim, D.-H., Relton, C, Ahn, Y.-O., and Hesketh, J. (2010). Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr. 5,215-223.
128. Thompson, I. M., Tangen, C. M., Klein, E. A., and Lippman, S. M. (2005). Phase III prostate cancer prevention trials: are the costs justified? J. Clin. Oncol. 23, 8161-8164.
129. Thomson, C. D. (2004a). Assessment of requirements for selenium and adequacy of selenium status: a review. Eur. J. Clin. Nutr. 58, 391-402.
130. Thomson, C. D. (2004b). Selenium and iodine intakes and status in New Zealand and Australia. Br. J. Nutr. 91, 661-672.
131. Thomson, C. D., Mclachlan, S. K., Parnell, W. R., Wilson, N., Wohlers, M., Scragg, R., Schaaf, D., and Fitzgerald, E. D. (2007). Serum selenium concentrations and dietary selenium intake of New Zealand children aged 5-14 years. Br. J. Nutr. 97, 357-364.
132. Thomson, C. D., and Robinson, M. F. (1990). Selenium content of foods consumed in Otago, New Zealand. N. Z. Med. J. 103, 130-135.
133. Thomson, C. D., and Robinson, M. F. (1996). The changing selenium status of New Zealand residents. Eur. J. Clin. Nutr. 50, 107-114.
134. Tsavachidou, D., Mcdonnell, T. J., Wen, S., Wang, X., Vakar-Lopez, F., Pisters, L. L., Pettaway, C. A., Wood, C. G., Do, K.-A., Thall, P. F., Stephens, C., Efstathiou, E., Taylor, R., Menter, D. G., Troncoso, P., Lippman, S. M., Logothetis, C. J., and Kim, J. (2009). Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J. Natl. Cancer Inst. 101, 306-320.
135. Van Ommen, B. (2007). Personalized nutrition from a health perspective: luxury or necessity? Genes Nutr. 2, 3-4.
136. van Ommen, B., Bouwman, J., Dragsted, L. O., Drevon, C. A., Elliott, R., De Groot, P., Kaput, J., Mathers, J. C., Muller, M., Pepping, F., Saito, J., Scalbert, A., Radonjic, M., Rocca-Serra, P., Travis, A., Wopereis, S., and Evelo, C. T. (2010a). Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes Nutr. 5, 189-203.
137. van Ommen, B., El-Sohemy, A., Hesketh, J., Kaput, J., Fenech, M., Evelo, C. T., McArdle, H. J., Bouwman, J., Lietz, G., Mathers, J. C., Fairweather-Tait, S., van Kranen, H., Elliott, R., Wopereis, S., Ferguson, L. R., Méplan, C., Perozzi, G., Allen, L., and Rivero, D. (2010b). The Micronutrient Genomics Project Working Group. The Micronutrient Genomics Project: a community-driven knowledge base for micronutrient research. Genes Nutr. 5, 285-296.
138. Van Ommen, B., Cavallieri, D., Roche, H. M., Klein, U. I., and Daniel, H. (2008). The challenges for molecular nutrition research 4: the "nutritional systems biology level." Genes Nutr. 3, 107-113.
139. Villette, S., Kyle, J. A. M., Brown, K. M., Pickard, K., Milne, J. S., Nicol, F., Arthur, J. R., and Hesketh, J. E. (2002). A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis. 29, 174-178.
140. Waters, D. J., Shen, S., Cooley, D. M., Bostwick, D. G., Qian, J., Combs, G. F. Jr., Glickman, L. T., Oteham, C., Schlittler, D., and Morris, J. S. (2003). Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J. Natl. Cancer Inst. 95, 237-241.
141. Waters, D. J., Shen, S., Glickman, L. T., Cooley, D. M., Bostwick, D. G., Qian, J., Combs, G. F. Jr., and Morris, J. S. (2005). Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 26, 1256-1262.
142. Williams, C. M., Ordovas, J. M., Lairon, D., Hesketh, J., Lietz, G., Gibney, M., and Van Ommen, B. (2008). The challenges for molecular nutrition research 1: linking genotype to healthy nutrition. Genes Nutr. 3, 41-49.
143. Wishart, D. S. (2007). Proteomics and the human metabolome project. Expert Rev. Proteomics 4, 333-335.
144. Wishart, D. S. (2009). Computational strategies for metabolite identification in metabolomics. Bioanalysis 1, 1579-1596.
145. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., Hau, D. D., Psychogios, N., Dong, E., Bouatra, S., Mandal, R., Sinelnikov, I., Xia, J., Jia, L., Cruz, J. A., Lim, E., Sobsey, C. A., Shrivastava, S., Huang, P., Liu, P., Fang, L., Peng, J., Fradette, R., Cheng, D., Tzur, D., Clements, M., Lewis, A., De Souza, A., Zuniga, A., Dawe, M., Xiong, Y., Clive, D., Greiner, R., Nazyrova, A., Shaykhutdinov, R., Li, L., Vogel, H. J., and Forsythe, I. (2009). HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603-D610.
146. Wittwer, J., Rubio-Aliaga, I., Hoeft, B., Bendik, I., Weber, P., and Daniel, H. (2011). Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives. Mol. Nutr. Food Res. 55, 1-18.
147. Xia, J., Bjorndahl, T. C., Tang, P., and Wishart, D. S. (2008). MetaboMiner - semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. BMC Bioinformatics 9, 507. doi: 10.1186/1471-2105-9-507
148. Xia, J., Psychogios, N., Young, N., and Wishart, D. S. (2009). MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652-W660.
149. Xia, J., and Wishart, D. S. (2010a). MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26, 2342-2344.
150. Xia, J., and Wishart, D. S. (2010b). MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 38(Suppl.), W71-W77.
151. Xia, L., Nordman, T., Olsson, J. M., Damdimopoulos, A., Bjorkhem-Bergman, L., Nalvarte, I., Eriksson, L. C., Arner, E. S. J., Spyrou, G., and Bjornstedt, M. (2003). The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol. Chem. 278, 2141-2146.
152. Xiong, Y. M., Mo, X. Y., Zou, X. Z., Song, R. X., Sun, W. Y., Lu, W., Chen, Q., Yu, Y. X., and Zang, W. J. (2010). Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease. Osteoarthr. Cartil. 18, 817-824.
153. Xu, X.-M., Carlson, B. A., Irons, R., Mix, H., Zhong, N., Gladyshev, V. N., and Hatfield, D. L. (2007a). Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem. J. 404, 115-120.
154. Xu, X.-M., Carlson, B. A., Zhang, Y., Mix, H., Kryukov, G. V., Glass, R. S., Berry, M. J., Gladyshev, V. N., and Hatfield, D. L. (2007b). New developments in selenium biochemistry: selenocysteine biosynthesis in eukaryotes and archaea. Biol. Trace Elem. Res. 119, 234-241.
155. Xue, W., Wang, Z., Chen, Q., Chen, J., Yang, H., and Xue, S. (2010). High selenium status in individuals exposed to arsenic through coal-burning in Shaanxi (PR of China) modulates antioxidant enzymes, heme oxygenase-1 and DNA damage. Clin. Chim. Acta 411, 1312-1318.
156. Yang, X.-E., Chen, W.-R., and Feng, Y. (2007). Improving human micronutrient nutrition through biofortification in the soil-plant system: China as a case study. Environ. Geochem. Health 29, 413-428.
157. Yuzbasioglu, A., Karatas, H., Gursoy-Ozdemir, Y., Saygi, S., Akalan, N., Soylemezoglu, F., Dalkara, T., Kocaefe, Y. C., and Ozguc, M. (2009). Changes in the expression of selenoproteins in mesial temporal lobe epilepsy patients. Cell. Mol. Neurobiol. 29, 1223-1231.
158. Zeisel, S. H. (2010). A grand challenge for nutrigenomics. Front. Genet. 1:2. doi: 10.3389/fgene.2010.00002
159. Zeng, H., and Botnen, J. H. (2007). Selenium is critical for cancer-signaling gene expression but not cell proliferation in human colon Caco-2 cells. Biofactors 31, 155-164.
160. Zhang, J., Dhakal, I. B., Lang, N. P., and Kadlubar, F. F. (2010a). Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk. Cancer Causes Control 21, 1437-1444.
161. Zhang, S., Rocourt, C., and Cheng, W.-H. (2010b). Selenoproteins and the aging brain. Mech. Ageing Dev. 131, 253-260.
162. Zhao, R., Domann, F. E., and Zhong, W. (2006). Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol. Cancer Ther. 5, 3275-3284.